LifespanningRx and RegenTherapy announced a strategic partnership to integrate CellGen Factors into the LifespanningRx longevity platform, expanding access to regenerative programs focused on cellular signaling, recovery, performance optimization and healthy aging.
The collaboration pairs LifespanningRx’s consumer-facing branding, commercialization infrastructure and membership model with RegenTherapy’s clinical integration, regenerative medicine expertise, fulfillment operations and therapeutic support systems. According to the company, CellGen Factors introduces a new category of regenerative optimization programs built around progressive cell signaling technologies and structured longevity protocols.
RegenTherapy will provide operational and clinical infrastructure, including fulfillment and onboarding support, and will manage initial distribution through its South Carolina facilities, while LifespanningRx will lead brand rollout, memberships, commercialization strategy, customer experience and platform expansion.
RegenTherapy leaders Dr Arvind Chakravarthy and Sanjiv Lal will serve as Cell Signaling Advisors. The partners are preparing coordinated launch initiatives, strategic partnerships and educational campaigns ahead of a public rollout in coming months.
